x

INTENSITY THERAPEUTICS, INC. (Nasdaq:INTS)

N/A • N/A
CIK 1567264
Company

Intensity Therapeutics, Inc. operates as biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.

Address
N/A
Employees
None
Stock Info
Close
$2.3200
Day Range
2.2600 - 2.3900
52 Week Range
1.5000 - 5.7800
Average volume
37.05K
Short Interest
51.51K (02/14/25)
% of Float Shorted
0.63%
Market Cap
$35.04M
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.1841
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
SEC filings
DateFormEvent
20 Dec, 2024 424B3
19 Dec, 2024 EFFECT
13 Dec, 2024 S-1
5 Dec, 2024 D
22 Nov, 2024 424B5
22 Nov, 2024 8-K
20 Nov, 2024 424B5
13 Nov, 2024 8-K
13 Nov, 2024 10-Q
23 Oct, 2024 4
23 Oct, 2024 8-K
23 Oct, 2024 4
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
17 Jul, 2024 8-K
11 Jul, 2024 EFFECT
11 Jul, 2024 EFFECT
9 Jul, 2024 CORRESP
9 Jul, 2024 CORRESP
8 Jul, 2024 UPLOAD
8 Jul, 2024 UPLOAD
3 Jul, 2024 S-8
3 Jul, 2024 S-3
3 Jul, 2024 S-3
3 Jul, 2024 8-K
7 Jun, 2024 4
7 Jun, 2024 SC 13G
4 Jun, 2024 DEFA14A
4 Jun, 2024 ARS
4 Jun, 2024 DEF 14A
24 May, 2024 8-K
15 May, 2024 3
15 May, 2024 4
15 May, 2024 8-K
10 May, 2024 8-K
9 May, 2024 10-Q
9 May, 2024 8-K
19 Apr, 2024 8-K
14 Mar, 2024 10-K
14 Mar, 2024 8-K
7 Mar, 2024 4
7 Mar, 2024 4
7 Mar, 2024 4
7 Mar, 2024 4
7 Mar, 2024 4
13 Feb, 2024 SC 13G
7 Feb, 2024 8-K
12 Dec, 2023 4
12 Dec, 2023 3
12 Dec, 2023 8-K
22 Nov, 2023 8-K
13 Nov, 2023 10-Q
13 Nov, 2023 8-K
5 Sep, 2023 8-K
22 Aug, 2023 S-8
14 Aug, 2023 10-Q
14 Aug, 2023 8-K
14 Aug, 2023 10-Q/A
21 Jul, 2023 4
10 Jul, 2023 8-K
5 Jul, 2023 8-K
30 Jun, 2023 CERT
30 Jun, 2023 424B4 IPO completed
29 Jun, 2023 3
29 Jun, 2023 3
29 Jun, 2023 3
29 Jun, 2023 3
29 Jun, 2023 EFFECT
29 Jun, 2023 3
29 Jun, 2023 3
29 Jun, 2023 S-1/A
29 Jun, 2023 S-1MEF
29 Jun, 2023 SEC STAFF
27 Jun, 2023 CORRESP
27 Jun, 2023 CORRESP
23 Jun, 2023 FWP
23 Jun, 2023 S-1/A
9 Jun, 2023 S-1/A
9 Jun, 2023 CORRESP
7 Jun, 2023 UPLOAD
1 Jun, 2023 FWP
18 May, 2023 S-1/A
14 Feb, 2023 CORRESP
14 Feb, 2023 CORRESP
13 Feb, 2023 FWP
9 Feb, 2023 CORRESP
9 Feb, 2023 CORRESP
9 Feb, 2023 FWP
8 Feb, 2023 CORRESP
8 Feb, 2023 CORRESP
6 Feb, 2023 CORRESP
6 Feb, 2023 CORRESP
27 Jan, 2023 S-1/A
27 Jan, 2023 CORRESP
23 Jan, 2023 UPLOAD
13 Jan, 2023 FWP
13 Jan, 2023 S-1/A
9 Nov, 2022 CORRESP
9 Nov, 2022 CORRESP
3 Nov, 2022 CORRESP
3 Nov, 2022 CORRESP
2 Nov, 2022 CORRESP
2 Nov, 2022 S-1/A
31 Oct, 2022 UPLOAD
18 Oct, 2022 SEC STAFF
13 Oct, 2022 CORRESP
13 Oct, 2022 CORRESP
13 Oct, 2022 CORRESP
13 Oct, 2022 CORRESP
13 Oct, 2022 SEC STAFF
11 Oct, 2022 CORRESP
11 Oct, 2022 CORRESP
3 Oct, 2022 S-1/A
3 Oct, 2022 CORRESP
29 Sep, 2022 UPLOAD
20 Sep, 2022 FWP
20 Sep, 2022 S-1/A
16 May, 2022 S-1/A
16 May, 2022 CORRESP
28 Apr, 2022 UPLOAD
26 Apr, 2022 SEC STAFF
20 Apr, 2022 S-1/A
20 Apr, 2022 FWP
7 Jan, 2022 S-1/A
7 Jan, 2022 FWP
16 Dec, 2021 FWP
10 Dec, 2021 CORRESP
10 Dec, 2021 CORRESP
9 Dec, 2021 UPLOAD
9 Dec, 2021 S-1/A
9 Dec, 2021 CORRESP
8 Dec, 2021 S-1/A
7 Dec, 2021 CORRESP
7 Dec, 2021 CORRESP
2 Dec, 2021 8-A12B/A
30 Nov, 2021 8-A12B
24 Nov, 2021 FWP
18 Nov, 2021 S-1/A
18 Nov, 2021 CORRESP
16 Nov, 2021 UPLOAD
12 Nov, 2021 S-1/A
12 Nov, 2021 CORRESP
9 Nov, 2021 UPLOAD
8 Nov, 2021 SEC STAFF
28 Oct, 2021 S-1
28 Oct, 2021 CORRESP
18 Oct, 2021 UPLOAD
20 Sep, 2021 DRS
Last update:2025-03-06 12:25:43.200880
INTENSITY THERAPEUTICS, INC. by TradingView

Sign Up to Subscribe